Literature DB >> 11938071

[Severe acute hepatitis induced by alendronate].

Christophe Carrère, Jean-Luc Duval, Bruno Godard, Jean-Pierre De Jaureguiberry, Jean-Marc Ciribilli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11938071

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN： 0399-8320


× No keyword cloud information.
  6 in total

1.  Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of bone.

Authors:  S A Polyzos; J Kountouras; A D Anastasilakis; I Litsas; M Kita; G Arsos; E Moralidis; E Terpos
Journal:  Osteoporos Int       Date:  2010-04-21       Impact factor: 4.507

Review 2.  Safety of long-term bisphosphonate therapy for the management of osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

3.  Alendronate effect in esophagus, stomach and liver: an animal based pathological study.

Authors:  Theodora Papamitsou; Sotiris Sotiriou; Apostolos Papakoulas; Alexandros Toskas; Dimitrios Kamperis; Sofia Karachrysafi; Eva-Maria Dietrich; Stergios Lialiaris; Antonia Sioga
Journal:  Histol Histopathol       Date:  2019-09-10       Impact factor: 2.303

4.  Hepatotoxicity induced by alendronate therapy.

Authors:  B Yanik; C Turkay; H Atalar
Journal:  Osteoporos Int       Date:  2007-01-17       Impact factor: 5.071

5.  Zoledronic acid-induced hepatotoxicity relieved after subsequent infusions in a Chinese woman with glucocorticoid-induced osteoporosis.

Authors:  Yan Jiang; Yong Fu; Xiao-ping Xing; Mei Li; Ou Wang; Wei-bo Xia; Xun-wu Meng
Journal:  Eur J Med Res       Date:  2015-08-22       Impact factor: 2.175

6.  Hepatotoxicity induced by zoledronic acid in an aged woman with primary osteoporosis.

Authors:  Yanhui Lu; Yu Pei; Yinghong Shao; Shuangtong Yan; Lichao Ma; Fusheng Fang; Mengmeng Jin; Minyan Liu; Jian Li; Chunlin Li
Journal:  EXCLI J       Date:  2013-02-13       Impact factor: 4.068
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.